Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development

To meet the growing demand for complex and high-concentration biologics, early insight into molecular properties has become essential in formulation development. Samsung Biologics offers a strategic approach combining predictive assessments and formulation optimization platforms. DEVELOPICK™ 3.0 enables early candidate evaluation using small protein quantities and enhanced in silico tools, while S-HiCon™ provides optimized high-concentration formulation conditions through a systematic screening workflow.

Discover how Samsung Biologics leverages these platforms to reduce development risk and accelerate formulation — supporting efficient, high-quality drug product development.

Key learning objectives:

• Learn how DEVELOPICK™ 3.0 enables early risk assessment with minimal protein input and enhanced in silico insights
• Understand how rapid hydrophobicity testing supports proactive formulation and process planning
• Discover how the S-HiCon™ platform helps define optimal conditions for high-concentration formulations over 100 mg/mL